14Oct2021 Califf Back at FDA? Moderna’s Booster Slam Dunk, & the Vaccine Equity Debate /Luke Timmerman/0/All14 Oct 2021 Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.